These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8245722)

  • 61. The lipid transport system in the mouse, Mus musculus: isolation and characterization of apolipoproteins B, A-I, A-II, and C-III.
    Forgez P; Chapman MJ; Rall SC; Camus MC
    J Lipid Res; 1984 Sep; 25(9):954-66. PubMed ID: 6436419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies.
    Koren E; Solter D; Lee DM; Reiner Z; McConathy WJ; Dashti N; Alaupovic P
    Biochim Biophys Acta; 1986 Mar; 876(1):91-100. PubMed ID: 3081046
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Metabolism of chylomicrons and very low density lipoproteins].
    Windler E
    Klin Wochenschr; 1990; 68 Suppl 22():19-22. PubMed ID: 2087074
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins.
    Falko JM; Schonfeld G; Witztum JL; Kolar JB; Salmon P
    Metabolism; 1980 Jul; 29(7):654-61. PubMed ID: 7382829
    [No Abstract]   [Full Text] [Related]  

  • 65. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Apo E-containing lipoproteins in low or high density lipoprotein deficiency.
    Gibson JC; Rubinstein A; Brown WV; Ginsberg HN; Greten H; Norum R; Kayden H
    Arteriosclerosis; 1985; 5(4):371-80. PubMed ID: 3925935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
    Jong MC; Havekes LM
    Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of artificial fat emulsions on the composition of serum lipoproteins in humans.
    Hailer S; Wolfram G
    Am J Clin Nutr; 1986 Feb; 43(2):225-33. PubMed ID: 3080868
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein.
    Connelly PW; Maguire GF; Hofmann T; Little JA
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):270-3. PubMed ID: 3467353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human apolipoprotein C-I: concentration in blood serum and lipoproteins.
    Polz E; Kotite L; Havel RJ; Kane JP; Sata T
    Biochem Med; 1980 Dec; 24(3):229-37. PubMed ID: 7283981
    [No Abstract]   [Full Text] [Related]  

  • 73. The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred.
    Zysow BR; Pullinger CR; Hennessy LK; Farese RV; Ghassemzadeh M; Kane JP
    Clin Genet; 1994 Jun; 45(6):292-7. PubMed ID: 7923858
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis.
    Nestel PJ; Huff MW; Billington T; Fidge NH
    Biochim Biophys Acta; 1982 Jul; 712(1):94-102. PubMed ID: 7115750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
    Campos E; Nakajima K; Tanaka A; Havel RJ
    J Lipid Res; 1992 Mar; 33(3):369-80. PubMed ID: 1569386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nephelometry of apolipoprotein B in human serum.
    Heuck CC; Schlierf G
    Clin Chem; 1979 Feb; 25(2):221-6. PubMed ID: 215342
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.
    Sprecher DL; Taam L; Gregg RE; Fojo SS; Wilson DM; Kashyap ML; Brewer HB
    J Lipid Res; 1988 Mar; 29(3):273-8. PubMed ID: 3379339
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human very low density lipoprotein structure: interaction of the C apolipoproteins with apolipoprotein B-100.
    Yang CY; Gu ZW; Valentinova N; Pownall HJ; Lee B; Yang M; Xie YH; Guyton JR; Vlasik TN; Fruchart JC
    J Lipid Res; 1993 Aug; 34(8):1311-21. PubMed ID: 8409765
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Separation and isolation of human apolipoproteins C-II, C-III0, C-III1, and C-III2 by chromatofocusing on the Fast Protein Liquid Chromatography system.
    Huff MW; Strong WL
    J Lipid Res; 1987 Sep; 28(9):1118-23. PubMed ID: 3655564
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.